Assessment of p53 and HER-2/neu genes status and protein products in oral squamous cell carcinomas

Romanian Journal of Morphology and Embryology

Volumn 54, Issue 4, 2013, Pages 1107-1113

  Stoicǎnescu, Dorina ^a   Andreescu, Nicoleta ^a   Belengeanu, Alina ^a   Meszaros, Noemi ^a   Cornianu, Mǎrioara ^b  

^a Department of Microscopic Morphology ^*  (Romania)

^b VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Fish technique; HER 2 neu gene; Immunohistochemistry; Oral squamous cell carcinoma; P53 gene

Indexed keywords

CANCER ANTIBODY; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERBB2 PROTEIN, HUMAN; PROTEIN P53;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHROMOSOME 17; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; MOUTH TUMOR; PATHOLOGY; SQUAMOUS CELL CARCINOMA; VERY ELDERLY;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTIBODIES, NEOPLASM; CARCINOMA, SQUAMOUS CELL; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; MOUTH NEOPLASMS; RECEPTOR, ERBB-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84891604823     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Tumino R, Vicario G, Head and neck cancers: oral cavity, pharynx, and larynx, Epidemiol Prev, 2004, 28(2 Suppl):28-33.
2. Argiris A, Karamouzis MV, Raben D, Ferris RL, Head and neck cancer, Lancet, 2008, 371(9625):1695-1709.
3. Greenlee RT, Hill-Harmon MB, Murray T, Thun M, Cancer statistics, 2001, CA Cancer J Clin, 2001, 51(1):15-36.
4. Parkin DM, Bray F, Ferlay J, Pisani P, Global cancer statistics, 2002, CA Cancer J Clin, 2005, 55(2):74-108.
5. Scully C, Field JK, Tanzawa H, Genetic aberrations in oral or head and neck squamous cell carcinoma (SCCHN): 1. Carcinogen metabolism, DNA repair and cell cycle control, Oral Oncol, 2000, 36(3):256-263.
6. Tsui IFL, Garnis C, Poh CF, A dynamic oral cancer field: unraveling the underlying biology and its clinical implication, Am J Surg Pathol, 2009, 33(11):1732-1738.
7. Ragin CCR, Modugno F, Gollin SM, The epidemiology and risk factors of head and neck cancer: a focus on human papillomavirus, J Dent Res, 2007, 86(2):104-114.
8. Gollin SM, Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease, Head Neck, 2001, 23(3):238-253.
9. Braakhuis BJ, Leemans CR, Brakenhoff RH, A genetic progression model of oral cancer: current evidence and clinical implications, J Oral Pathol Med, 2004, 33(6):317-322.
10. Tsantoulis PK, Kastrinakis NG, Tourvas AD, Laskaris G, Gorgoulis VG, Advances in the biology of oral cancer, Oral Oncol, 2007, 43(6):523-534.
11. Hopman AH, Voorter CE, Ramaekers FC, Detection of genomic changes in cancer by in situ hybridization, Mol Biol Rep, 1994, 19(1):31-44.
12. Khandekar SP, Bagdey PS, Tiwari RR, Oral cancer and some epidemiological factors: a hospital based study, Indian J Commun Med, 2006, 31(3):157-159.
13. El-Husseiny G, Kandil A, Jamshed A, Khafaga Y, Saleem M, Allam A, Al-Rajhi N, Al-Amro A, Rostom AY, Abuzeid M, Otieschan A, Flores AD, Squamous cell carcinoma of the oral tongue: an analysis of prognostic factors, Br J Oral Maxillofac Surg, 2000, 38(3):193-199.
14. Schantz SP, Yu GP, Head and neck cancer incidence trends in young Americans, 1973-1997, with a special analysis for tongue cancer, Arch Otolaryngol Head Neck Surg, 2002, 128(3):268-274.
15. Tramacere I, Negri E, Bagnardi V, Garavello W, Rota M, Scotti L, Islami F, Corrao G, Boffetta P, La Vecchia C, A meta-analysis of alcohol drinking and oral and pharyngeal cancers. Part 1: Overall results and dose-risk relation, Oral Oncol, 2010, 46(7):497-503.
16. Grizzi F, Di Ieva A, Russo C, Frezza EE, Cobos E, Muzzio PC, Chiriva-Internati M, Cancer initiation and progression: an unsimplifiable complexity, Theor Biol Med Model, 2006, 3:37.
17. Mehta V, Yu GP, Schantz SP, Population-based analysis of oral and oropharyngeal carcinoma: changing trends of histopathologic differentiation, survival and patient demographics, Laryngoscope, 2010, 120(11):2203-2212.
18. Arduino PG, Carrozzo M, Chiecchio A, Broccoletti R, Tirone F, Borra E, Bertolusso G, Gandolfo S, Clinical and histopathologic independent prognostic factors in oral squamous cell carcinoma: a retrospective study of 334 cases, J Oral Maxillofac Surg, 2008, 66(8):1570-1579.
19. Jemal A, Siegel R, Xu J, Ward E, Cancer statistics, 2010, CA Cancer J Clin, 2010, 60(5):277-300.
20. Marur S, Forastiere AA, Head and neck cancer: changing epidemiology, diagnosis, and treatment, Mayo Clin Proc, 2008, 83(4):489-501.
21. Figueiredo ML, Kim Y, Zhou XC, Myers JN, Wong DDT, Molecular mechanisms of head and neck cancer, Drug Discov Today, 2004, 1(2):273-281.
22. Homann N, Nees M, Conradt C, Dietz A, Weidauer H, Maier H, Bosch FX, Overexpression of p53 in tumor-distant epithelia of head and neck cancer patients is associated with an increased incidence of second primary carcinoma, Clin Cancer Res, 2001, 7(2):290-296.
23. Carlos de Vicente J, Junquera Gutiérrez LM, Zapatero AH, Fresno Forcelledo MF, Hernández-Vallejo G, López Arranz JS, Prognostic significance of p53 expression in oral squamous cell carcinoma without neck node metastases, Head Neck, 2004, 26(1):22-30.
24. Angiero F, Sordo RD, Dessy E, Rossi E, Berenzi A, Stefani M, Sidoni A, Comparative analysis of c-erbB-2 (HER-2/neu) in squamous cell carcinoma of the tongue: does over-expression exist? And what is its correlation with traditional diagnostic parameters? J Oral Pathol Med, 2008, 37(3):145-150.
25. Edström S, Cvetkovska E, Westin T, Young C, Overexpression of p53-related proteins predicts rapid growth rate of head and neck cancer, Laryngoscope, 2001, 111(1):124-130.
26. Lippman SM, Sudbø J, Hong WK, Oral cancer prevention and the evolution of molecular-targeted drug development, J Clin Oncol, 2005, 23(2):346-356.
27. Nylander K, Dabelsteen E, Hall PA, The p53 molecule and its prognostic role in squamous cell carcinomas of the head and neck, J Oral Pathol Med, 2000, 29(9):413-425.
28. Khan AJ, King BL, Smith BD, Smith GL, DiGiovanna MP, Carter D, Haffty BG, Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma, Clin Cancer Res, 2002, 8(2):540-548.
29. Scheer M, Prange W, Petmecky K, Schirmacher P, Zöller JE, Kübler AC, Überexpression/Amplifikation des her-2/neu- Protoonkogens in oralen Plattenepithelkarzinomen, Mund-, Kiefer- and Gesichtschirurgie, 2003, 7(3):138-145.
30. Gancberg D, Lespagnard L, Rouas G, Paesmans M, Piccart M, Di Leo A, Nogaret JM, Hertens D, Verhest A, Larsimont D, Sensitivity of HER-2/neu antibodies in archival tissue samples of invasive breast carcinomas. Correlation with oncogene amplification in 160 cases, Am J Clin Pathol, 2000, 113(5): 675-682.
31. Rautava J, Jee KJ, Miettinen PJ, Nagy B, Myllykangas S, Odell EW, Soukka T, Morgan PR, Heikinheimo K, ERBB receptors in developing, dysplastic and malignant oral epithelia, Oral Oncol, 2008, 44(3):227-235.
32. Bernardes VF, Gleber-Netto FO, Sousa SF, Silva TA, Aguiar MC, Clinical significance of EGFR, Her-2 and EGF in oral squamous cell carcinoma: a case control study, J Exp Clin Cancer Res, 2010, 29:40.